Skip to content

New-Generation GMA Laryngeal Mask Airway Versus Conventional Inflatable Laryngeal Mask Airway

A Multicenter, Randomized Controlled Study Comparing the Effectiveness of the New Generation GMA Laryngeal Mask and Conventional Laryngeal Mask in Airway Management During General Anesthesia

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07177586
Enrollment
1384
Registered
2025-09-17
Start date
2025-09-18
Completion date
2027-07-31
Last updated
2026-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Supraglottic Airway Devices Position

Keywords

supraglottic airway device, laryngeal mask

Brief summary

This study aims to compare the new-generation GMA laryngeal mask airway (LMA) with the traditional inflatable LMA in patients undergoing elective surgery under general anesthesia. The primary objectives are to evaluate the safety, effectiveness, stability, ease of use, and patient comfort of the GMA LMA, providing practical guidance for clinical airway management. Additionally, this research will analyze the anatomical positioning and sealing mechanism of the LMA to identify factors influencing proper alignment and airway sealing. The findings may contribute to future improvements in LMA design, enhancing patient safety and procedural success. This study is designed for healthcare providers, anesthesiologists, and researchers seeking evidence-based recommendations for LMA selection in clinical practice. Participation involves standard anesthesia procedures with close monitoring to ensure patient safety.

Detailed description

Eligible patients meeting the inclusion criteria were enrolled in the study and randomly assigned into two groups using a random number table: the traditional Inflatable Laryngeal Mask Airway Group (Group L) and the GMA Group (Group G). One day before surgery, the research team conducted preliminary screening of patients scheduled for elective surgery, followed by a preoperative visit to explain the study's purpose, anesthesia considerations, and obtain informed consent. Upon entering the operating room, standard monitoring (ECG, blood pressure, pulse oximetry, etc.) was applied. The research team recorded the patient's actual fasting duration, last intake (food/liquid type), and baseline characteristics, including age, sex, height, weight, BMI, comorbidities, ASA classification, surgical type, and preoperative anxiety level. Airway assessment was reconfirmed. Anesthesia induction was performed with intravenous etomidate, vecuronium, and sufentanil. After loss of consciousness and disappearance of the eyelash reflex, manual ventilation was initiated. Following induction, the laryngeal mask was inserted.

Interventions

DEVICEGMA Laryngeal Mask Airway

The GMA-Tulip is a new single-use supraglottic airway device (SAD). Device size is selected based on the patient's weight and height, following manufacturer guidelines.

DEVICEInflatable Laryngeal Mask Airway

The comparator is a conventional inflatable Laryngeal Mask Airway (LMA) of appropriate size (selected by weight/height), inserted using standard clinical protocols.

Sponsors

First Affiliated Hospital of Zhejiang University
Lead SponsorOTHER
The Second Affiliated Hospital of Zhejiang Chinese Medical University
CollaboratorOTHER
Red Cross Hospital, Hangzhou, China
CollaboratorOTHER
Hangzhou Hospital of Traditional Chinese Medicine
CollaboratorOTHER
Lanxi People's Hospital
CollaboratorOTHER
Ningbo Medical Center Lihuili Hospital
CollaboratorOTHER_GOV
The Second Affiliated Hospital of Jiaxing University
CollaboratorOTHER
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
CollaboratorOTHER
Ruijin Hospital
CollaboratorOTHER
The Central Hospital of Lishui City
CollaboratorOTHER
Lishui Country People's Hospital
CollaboratorOTHER
Sir Run Run Shaw Hospital
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Inclusion Criteria 1. Age 18-75 years; 2. ASA physical status I-II; 3. Strict compliance with ASA fasting guidelines; 4. Normal airway anatomy; 5. Voluntary participation with signed informed consent. *

Exclusion criteria

1. Pre-existing aspiration risk or gastrointestinal disorders; 2. Oropharyngeal/laryngeal abnormalities; 3. Anticipated difficult airway (≥1 of the following): BMI \>30 kg/m² Mouth opening \<3 cm Mallampati class III-IV Restricted neck mobility 4. Contraindications to LMA use; 5. Communication or cognitive impairments; 6. Other exclusions at investigator's discretion

Design outcomes

Primary

MeasureTime frameDescription
Success rate of anatomical alignment of laryngeal maskDuring LMA placement (immediately after insertion)Comparison of anatomical positioning success rates between inflatable LMA and GMA-Tulip LMA, assessed by fiberoptic bronchoscopy (FOB).

Secondary

MeasureTime frameDescription
Sealing pressure and positional stability of the GMA-Tulip versus inflatable LMAIntraoperative period (from LMA insertion until removal at end of surgery)Assess the stability and anti-displacement properties of special body positions (e.g. lateral decubitus, Trendelenburg position) and the laryngeal mask airway under pneumoperitoneum.
First-attempt success rate of LMAduring procedureFirst-attempt success: Successful placement of the laryngeal mask airway on the first attempt without requiring reinsertion
Time to Successful Placement of LMAduring procedureDuration (in seconds) from LMA insertion into the oral cavity until final correct positioning is achieved
Hemodynamic response to LMA insertion and removalIntraoperative periodParameters: Systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP) (measured non-invasively or invasively).
Oxygenation Stability (Intraoperative)From patient entry into operating room to the time for LMA removalPeripheral oxygen saturation (SpO₂) (%) measured by continuous pulse oximetry
Ventilation Parameters (Intraoperative)from the start of mechanical ventilation after LMA placement to LMA removalThe measurement of Peak Airway Pressure (Ppeak) in cmH₂O is typically obtained through real-time monitoring by the anesthesia machine's ventilator system.
Feasibility of gastric tube insertion through LMADuring LMA placement (after confirmation of correct LMA position).Success rate: Proportion of cases with successful gastric tube placement
LMA-Related ComplicationsDay 0Immediate complications: Visible blood on removal (graded: none/mild/moderate/severe), sore throat , hoarseness, aspiration. Pain assessment: NRS for sore throat .
Patient Tolerance ScoreWithin 60 minutes after LMA removalGrade I (Excellent Tolerance) to Grade IV (Severe Intolerance)
Anesthesiologist Satisfaction SurveyWithin 30 minutes after surgery completionScale: 1-10 (1 = Very dissatisfied, 10 = Very satisfied)
Surgeon Satisfaction AssessmentWithin 30 minutes after surgery completionScale: 1-10 (1 = Very dissatisfied, 10 = Very satisfied)
Patient Satisfaction SurveyWithin 24 hours after surgeryScale: 1-10 (1 = Very uncomfortable, 10 = Very comfortable)
Ultrasonographic Assessment of Gastric Antrum Cross-Sectional Area (CSA) in Supine Position for Monitoring Gastric InsufflationBaseline: Within 10 minutes before anesthesia induction; Post-intervention: Within 3 minutes after successful LMA placement; Postoperative: After surgical closure but before LMA removalThis protocol utilizes point-of-care ultrasound (POCUS) to measure gastric antrum cross-sectional area (CSA) in supine patients, evaluating the risk of perioperative gastric insufflation caused by LMA.

Countries

China

Contacts

CONTACTXiangming Fang, Doctor
xmfang@zju.edu.cn8613867161019
PRINCIPAL_INVESTIGATORXiangming Fang

Zhejiang University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026